secwatch.observer — SEC 8-K summary
======================================

Issuer:     Trevi Therapeutics, Inc. (TRVI)
CIK:        0001563880
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0000950170-23-012870
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trevi Therapeutics amends bylaws to update proxy rules and meeting procedures
-----------------------------------------------------------------------------

- Eliminated requirement for stockholder list to be available at meeting.
- Added provisions for adjourning meetings due to technical failure in remote communication.
- Enhanced disclosure requirements for stockholder nominations under universal proxy rules (Rule 14a-19).
- Company may disregard nominations if stockholders fail to comply with Rule 14a-19 solicitation requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563880/000095017023012870/0000950170-23-012870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563880/000095017023012870/trvi-20230413.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer